Mono di & tri cyclic compounds useful for lowering ige concentrations
AssigneeThe Research Foundation of State University of New York
InventorsHelen Durkin, Martin Bluth, Tamar Smith-Norowitz, Rauno Joks, Alexander Kiselyov
Life of this patent
Estimating the term…
Abstract
The present invention is directed novel compounds which are derivatives of minocycline or doxycycline, pharmaceutical compositions containing same and use thereof in lowering excess IgE levels in a mammal suffering from a disease where IgE is pathogenic.
Claims22
A compound having the formula
A compound or pharmaceutically acceptable salt thereof where the compound has the formula
A compound or pharmaceutically acceptable salt thereof where the compound has the formula
A compound or pharmaceutically acceptable salt thereof where the compound has the formula
A compound or pharmaceutically acceptable salt thereof where the compound has the formula
A compound or pharmaceutically acceptable salt thereof where the compound has the formula
A compound or pharmaceutically acceptable salt thereof where the compound has the formula
A compound or pharmaceutically acceptable salt thereof where the compound has the formula
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.